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Abstract  
 
Purpose: To suppress partial volume effect in brain PET, there has been many algorithms 
proposed. However, each methodology has different property due to its assumption and 
algorithms. Our aim of this study was to investigate the difference among PVC method for tau 
and amyloid PET study.  
 
Method: We investigated two of the most commonly used partial volume correction (PVC) 
methods, Müller-Gärtner (MG) and geometric transfer matrix (GTM) and also other three 
methods for clinical tau and amyloid PET imaging. One healthy control (HC) and one 
Alzheimer’s disease (AD) PET studies of both [18F]THK5351 and [11C]PIB were performed using 
a Eminence STARGATE scanner (Shimadzu Inc., Kyoto, Japan). All PET images were corrected 
for partial volume effect (PVE) by MG, GTM, Labbé (LABBE), Regional voxel-based (RBV), 
and Iterative Yang (IY) methods, with segmented or parcellated anatomical information 
processed by FreeSurfer, derived from individual MR images. PVC results of 5 algorithms were 
compared with the uncorrected data.  
 
Results: In regions of high uptake of [18F]THK5351 and [11C]PIB, different PVCs demonstrated 
different SUVRs. The degree of difference between PVE uncorrected and corrected depends on 
not only PVC algorithm but also type of tracer and subject condition. 
 
Conclusion: Presented PVC methods are straight-forward to implement but the corrected images 
require careful interpretation as different methods result in different levels of recovery. 
 
Key words: Partial volume correction, tau PET, image processing, [18F]THK5351 
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Introduction 
In vivo brain imaging of neurofibrillary tangle (tau) and amyloid E peptide (amyloid) using 
Positron Emission Tomography (PET) has been recognized as having an important role in the 
diagnosis of early Alzheimer’s disease (AD) (1). However, the PET image always suffers from 
partial volume effect (PVE) due to the spatial resolution of PET system, where regional uptake of 
radiotracer is blurred and its quantification is degraded (2).  
To compensate PVE on PET images, there have been many partial volume correction (PVC) 
methods proposed. For brain PET studies, both the spatial resolution and individual structural 
images have been utilized for PVC. This is particularly relevant with the development of 
PET/MRI scanner (3, 4). The classical and popular PVC methods for brain PET which utilize 
structural information, are Müller-Gärtner (MG) (5) and the geometric transfer matrix (GTM) 
methods (6). MG is a voxel-based method and assumes that uptake in white matter can be 
accurately represented by its mean value. GTM is a region-of-interest (ROI) based method and 
assumes a uniform distribution within each ROIs.  
There have been several reports which state that applying PVC improved image quality of 
tau and amyloid PET and improved the accuracy and precision of the quantification of tracer 
uptake (7-16). However, in many cases, the applied PVC method were limited to MG or GTM. 
Furthermore, Greve et al. reported that different PVC methods (MG, GTM, and Meltzer) result 
in different conclusions in a FDG cross-sectional aging study of elderly subjects (17). There is a 
need to perform a comparison study of the popular PVC methods for tau and amyloid PET studies 
and to explore the possibility of other PVC techniques. In this study, we report 5 methods for tau 
and amyloid PET images: traditional MG, GTM, and other 3 methods. The methodology was 
applied to PET images of a single HC and AD subjects having both [18F]THK5351 and [11C]PIB 
studies.  
 
Material and Methods 
Clinical studies 
PET and MR images of 1 HC (81 y.o., Female) and 1 AD (80 y.o., Male) subjects, who had 
both a [11C]PIB and [18F]THK5351 PET scan, were used in this study. The PET studies were 
performed using Eminence STARGATE (Shimadzu Inc., Kyoto, Japan) with 3.5-mm (transaxial) 
and 5.0 mm (axial) full width at half maximum (FWHM) resolution at 1.0 cm off-center of the 
field of view. After a 10-min 131Cs transmission scan, 60- and 70-min dynamic scanning was 
started immediately after the intravenous administration of 304.9-347.4 MBq [11C]PIB and 176.1-
178.0 MBq [18F]THK5351, respectively. All emission data were reconstructed using 3D-DRAMA 
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(1 iteration, 128 filter cycle, 30 relaxation factor) (18) with attenuation and scatter corrections 
(19) and post filter of three dimensional Gaussian (3 mm FWHM). SUV images with 40-60 min 
time frame images were obtained. All subjects underwent T1-weighted magnetic resonance 
imaging (MRI) scans using a Signa 1.5-T machine (General Electric Inc., Milwaukee, WI, USA). 
Image matrix of reconstructed PET and MRI were 128 × 128 × 79 (2.0 × 2.0 × 2.6 mm) and 256 
× 256 × 124 (0.98 × 0.98 × 1.4 mm), respectively. 
This study was approved by the Ethics Committee on Clinical Investigations of Tohoku 
University School of Medicine and was performed in accordance with the Declaration of Helsinki. 
Written informed consent was obtained from all subjects after a complete description of the study 
had been provided. 
 
Partial Volume Correction methods 
5 PVC methods, MG (5), GTM (6, 20), Labbé (LABBE) (21), Regional voxel-based (RBV) 
(22), and Iterative Yang (IY) (3), were performed in this study and are described briefly below. 
Abbreviations are defined in Table. 1.   
The MG (5) is voxel-based method for gray matter regions with the assumption of uniform-
tracer uptake in white matter. Basic concept of MG is that uncorrected PET image, f(x), can be 
decomposed into gray matter and white matter (CSF if necessary) components. PVE corrected 
PET image of gray matter region, fc,gray(x), is estimated by the subtraction from f(x) to smoothed 
PET image of white matter region and then divided by gray matter fractions in each pixel, as 
follows. 
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where T is the geometric transfer matrix of tij, which represents the contribution of spill-over 
from Di into Dj.  
The LABBE (21) is also a ROI-based method. LABBE also utilizes the assumption that PET 
image can be decomposed into regions where can be regarded as the uniform activity within it. 
Sets of PET value at each voxel,[ f (x1), f(x2), ….., f(xM)], is multiplied with inverse-matrix of T 
(f = T  C) and then corrected values, Ci,f(x), for every region are obtained as follows, 
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Where T is the matrix calculated by PSFpi(x) and M is the total pixel number.  
The RBV (22) is an extension of the GTM and the voxel-wise correction of Yang et al.(23). 
Basic concept of RBV is to multiply uncorrected PET image f(x) with PVE correction factor in 
each voxel. The factor is derived from the ratio between synthetic PET image, consists of PVE 
corrected ROI values by GTM, and smoothed synthetic PET image as follows; 
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The Iterative Yang (IY) (3) is similar with RBV but a further adaptation of the Yang method 
(23). This process is iterated several times with iteration number k (where iteration number was 
set to 5 in this study). PVE correction factor for IY is derived from the ratio between synthetic 
PET image, consists of ROI value of k-th corrected fck(x) and smoothed synthetic PET image as 
follows, 
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Data Processing and Analysis 
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The subject MR image was parcellated using the FreeSurfer software package 
(surfer.nmr.mgh.harvard.edu) version 5.1 (24-27). FreeSurfer extracts cortical surface meshes 
from the structural MR and assigns anatomical labels based on probabilistic data derived from a 
manually labeled training set. All processing using FreeSurfer was performed without any manual 
intervention by the user, except for the hippocampus of the AD subject. The hippocampi of the 
AD subject was manually re-drawn and carefully checked by a physician because FreeSurfer 
overestimated volume of atrophied thin hippocampi by including enlarged ventricles. The detailed 
parcellation produced by FreeSurfer was then mapped into 50 regions. The assignment of these 
regions is shown in supplementary table 1.  
PVC images after MG, GTM, LABBE, RBV, and IY correction were implemented using the 
PETPVC toolbox (https://github.com/UCL/PETPVC) (28) and were applied assuming a 
resolution of 5 mm FWHM. 10 iterations were performed for IY. Both uncorrected and PVC 
images with [18F]THK5351 and [11C]PIB were normalized with averaged ROI value in cerebellar 
grey matter to generate SUVR images. Through ROI analysis, we evaluated the effect of the 
different 5 PVC algorithms. 
 
Results  
Figure 1 and 2 shows the uncorrected and 2 voxel-based PVC SUVR images of 1 AD and 1 
HC with [18F]THK5351 and [11C]PIB, respectively. After PVCs of the AD subject by RBV and 
MG, hippocampal SUVR of [18F]THK5351 (Figure 1 upper) and cortical the SUVR of [11C]PIB 
(Figure 2 upper) were visually increased compared with the uncorrected. Figure 3 shows SUVR 
values of uncorrected PET images, 3 voxel-based and 2 ROI-based PVC results of the HC and 
AD subjects, for both tracers. Figure 4 also shows %difference of SUVR for 5 PVCs against the 
uncorrected. For AD subject, the amount of recovery by RBV and IY were almost the same, 
similar with that of GTM, but different from those of MG and LABBE (e.g. hippocampus of AD 
in [18F]THK5351 and frontal of AD in [11C]PIB) (Figure 4A and 4B). For HC subject, MG 
showed small increase of tracer uptake compared with other 4 methods (Figure 4C and 4D).  
   
Discussion 
In the present study, we compared five partial volume correction methods for tau and amyloid 
PET imaging. Subjects undergoing tau and amyloid PET imaging are often expected to have brain 
atrophy, with or without physiological change in the region. It is difficult to accurately quantify 
tracer uptake in atrophic regions due to PVE. PVC for tau and amyloid PET imaging is expected 
to compensate PVE for more accurate quantification of tracer uptake, and is therefore essential 
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for these applications (10). 
 However, the present results suggest that most PVC techniques can produce different amounts 
of recovery in each region, subject condition, and tracer, even though RBV and IY showed the 
same results. In particular, MG showed different amount of recovery between subject conditions. 
Thomas et al previously investigated the quantification of PVCs (RBV, MG, modified MG, 
deconvolution approach Van-Cittered) on [11C]PIB human mimicked brain Phantom with two 
conditions, HC and AD (22). Notably, after PVC of MG, overestimation of [11C]PIB uptake in the 
hippocampal region of an AD phantom was observed, even though that of a HC phantom was not 
(22). We also observed a similar tendency with this correction technique. This indicates that tracer 
uptake in the hippocampal region after MG PVC may lead to a misinterpretation of pathological 
change. 
Limitation of the study is only two subjects involved, therefore, it is difficult to conclude 
directionality of what PVC would be better. In this paper, we showed the potential that different 
PVC may cause different quantitative values and distributions. PVC is sensitive to errors in image 
processing, for example of mis-segmentation of, and mis-co-registration to, an anatomical image, 
and appropriate setting of the estimated PSF for corrections. Not only algorithms but also these 
sources of error propagation need to be considered carefully to increase potential usage of PV-
corrected PET images. These are out of scope of this report but in order to compare and optimize 
the algorithm of PVC, further simulation and clinical studies with sufficient number of the subject 
would be necessary and this will be our future work. 
 
Conclusion 
PVC is essential processing when studying populations that are likely to have atrophy. However, 
in regions of high uptake of [18F]THK5351 and [11C]PIB, different PVCs demonstrated different 
SUVRs. The degree of difference between PVE uncorrected and corrected data depends on not 
only PVC algorithm but also subject/patient disease. Presented PVC methods are straight-forward 
to implement but careful interpretation of the results is necessary.  
 
 
 
Figure and Table legends 
Figure 1. Uncorrected and two PVC SUVR images for single HC and AD subject with 
[18F]THK5351 
Figure 2. Uncorrected and 2 PVC SUVR images for single HC and AD subject with [11C]PIB  
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Figure 3. ROI comparison of uncorrected and PVC SUVRs for a HC and AD subject with 
[18F]THK5351 and [11C]PIB. 
Figure 4. %Difference between uncorrected and PVC SUVRs for a HC and AD subject with 
[18F]THK5351 and [11C]PIB. 
 
Table 1. Definitions and abbreviations for PVC processing 
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Table 1. Definitions and abbreviations for PVC processing 
Abbreviation Description 
f(x) uncorrected PET image  
fc(x) PVE corrected PET image 
fs(x) synthetic PET image 
pi(x) anatomical probability of i-th region at location 𝑥  
N the total number of regions 
A i, f(x) Averaged value of f(x) at i-th region 
Ci, f(x) PVE corrected value for f(x) at i-th region 
Di Volume of i-th region   
PSF  Point spread function  
 Operation of three-dimensional convolution integral. 
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